scispace - formally typeset
Search or ask a question
Institution

Roussel Uclaf

About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid


Papers
More filters
Patent
20 Sep 1982
TL;DR: In this article, the triazoloquinazolones were used as ingredients for anti-histamines and bronchospasmolytiques, including anti-malignancy agents.
Abstract: L'invention concerne les triazoloquinazolones The invention relates triazoloquinazolones ou R et R' sont hydrogene, halogene, alcoyle ou alcoxy (1 a 3 carbones) et nitro, Y est alcoyle (1 a 6 carbones), cycloalcoyle (3 a 8 carbones), alcenyle (2 a 4 carbones), aryle ou aralcoyle (6 a 8 carbones), B est wherein R and R 'are hydrogen, halogen, alkyl or alkoxy (1-3 carbons) and nitro, Y is alkyl (1 to 6 carbons), cycloalkyl (3 to 8 carbons), alkenyl (2-4 carbons), aryl or aralkyl (6 to 8 carbons), B is ou alcoylene -(CH 2 )n- ou n est 1, 2 ou 3, alkylene or - (CH 2) n- wherein n is 1, 2 or 3, ou R 1 et R 2 sont hydrogene, alcoyle (1 a 6 carbones), cycloalcoyle (3 a 8 carbones), aryle ou aralcoyle (6 a 8 carbones), aminoalcoyle, monoalcoyle ou dialcoylaminoalcoyle (alcoyles de 2 a 4 carbones, piperidinoalcoyle, morpholinoalcoyle ou piperazinylalcoyle, ou R, et R 2 forment avec l'azote un heteroxycle sature mono ou bicyclique (4 a 8 carbones), pouvant porter 1 ou 2 methyles, ou renfermer un oxygene, un soufre ou un azote qui peut etre substitue par alcoyle (1 a 3 carbones), hydroxyalcoyle (1 a 3 carbones), aryl ou aralcoyle (6 a 8 carbones) ou alcoxycarbonyle (2 a 5 carbones) ou X est wherein R 1 and R 2 are hydrogen, alkyl (1 to 6 carbons), cycloalkyl (3 to 8 carbons), aryl, or aralkyl (6 to 8 carbons), aminoalkyl, monoalkyl or dialkylaminoalkyl (alkyl from 2 to 4 carbons, piperidinoalcoyle, morpholinoalcoyle or piperazinylalcoyle, or R, and R 2 form with the nitrogen a saturated mono or bicyclic heteroxycle (4-8 carbons), which may have 1 or 2 methyl or contain oxygen, sulfur or nitrogen which may be substituted by alkyl (1-3 carbons), hydroxyalkyl (1-3 carbons), aryl or aralkyl group (6-8 carbons) or alkoxycarbonyl (2 to 5 carbons) or X is leurs sels avec les acides, leur preparation, leur application comme medicaments notamment antihistaminiques et bronchospasmolytiques. salts with acids, their preparation, their use as medicaments including antihistamines and bronchospasmolytic. les compositions les renfermant et des intermediaires nouveaux. compositions containing them and novel intermediates.

7 citations

Journal ArticleDOI
TL;DR: This project had a technological aim to qualify the design and the technologies used, and a more scientific one to improve understanding of the phenomena involved in this process.

7 citations

Patent
12 May 1982
TL;DR: In this paper, the syn isomers of optically active isomers and racemates of 7-[2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido]-bicyclooctene-carboxylic acid derivatives of the formula ##STR1## were selected from the group consisting of hydrogen, an alkali metal, --NH 4, alkaline earth metal equivalent, a non-toxic, pharmaceutically acceptable organic amine and an easily cleavable ester group.
Abstract: Novel syn isomers of optically active isomers and racemates of 7-[2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido]-bicyclooctene-carboxylic acid derivatives of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, optionally substituted alkyl of 1 to 6 carbon atoms and optionally substituted alkenyl and alkynyl of 2 to 6 carbon atoms, R 1 is selected from the group consisting of hydrogen, methyl, halomethyl, hydroxymethyl and acyloxymethyl, X is selected from the group consisting of oxygen and optionally oxidized sulfur, A is selected from the group consisting of hydrogen, an alkali metal, --NH 4 , alkaline earth metal equivalent, a non-toxic, pharmaceutically acceptable organic amine and an easily cleavable ester group and their non-toxic, pharmaceutically acceptable acid addition salts having antibiotic activity and their preparation.

7 citations

Patent
06 Jan 1993
TL;DR: A compound selected from the group consisting of a compound of the formula "STR1" wherein R 1 is selected from a group consisting consisting of R 13, R 14 and R 15 are individually selected from each of the groups consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms, n is an integer from 0, 1, 2 or 3; Hal, Hal 1, Hal 2 and Hal 3 are individually halogen; and R 8, R 9, R 10, R 11, R 12, R 13 and R 14 are individually any of the
Abstract: A compound selected from the group consisting of a compound of the formula ##STR1## wherein R 1 is selected from the group consisting of ##STR2## R 13 , R 14 and R 15 are individually selected from the group consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms, n is an integer from 1 to 3, R 2 is hydrogen or alkyl of 1 to 3 carbon atoms, R 3 , R 4 R 5 , R 6 and R 7 are individually selected from the group consisting of hydrogen, halogen, --NO 2 , --CN, alkyl, alkylthio and alkoxy of 1 to 6 carbon atoms, alkylcarbonyl of 2 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, ##STR3## m is 0, 1, 2 or 3, n is 1, 2 or 3; Hal, Hal 1 , Hal 2 and Hal 3 are individually halogen and ##STR4## R 8 , R 9 , R 10 , R 11 and R 12 are individually any of the groups defined above for R 3 , R 4 , R 5 , R 6 and R 7 or R 4 and R 5 together form --O--CH 2 --O-- and their non-toxic, pharmaceutically acceptable base addition salts having anti-inflammatory activity.

7 citations

Patent
Velluz Leon1, Amiard Gaston1, Bartos Jaroslav1, Goffinet Bernard1, Heymes Rene1 
29 Mar 1957

7 citations


Authors

Showing all 1888 results

NameH-indexPapersCitations
Fernand Labrie11088548308
Lionel H. Opie8451925964
Alain Bélanger7024416469
Michel J. Tremblay5327310485
Pierre Monsan512168049
Samir Z. Zard5057510739
Alejandro Aruffo4712314084
Samuel S.C. Yen47966865
Dominique Maraninchi471888108
Serge Erlinger461528200
Romain Lefebvre402215269
William B. Motherwell393056357
Jean-Pierre Raynaud381045075
André Lemay381144264
Patrick J. Creaven321023435
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

85% related

Novartis
50.5K papers, 1.9M citations

85% related

Pfizer
37.4K papers, 1.6M citations

84% related

Eli Lilly and Company
22.8K papers, 946.7K citations

84% related

AstraZeneca
23.4K papers, 938.2K citations

82% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20181
20114
20104
20091
20084
20072